Lung Cancer
EA5162
Phase II Study of Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations in EGFR
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Physician Fact Sheet
